Tango Therapeutics, Inc. (TNGX): Price and Financial Metrics


Tango Therapeutics, Inc. (TNGX): $6.22

0.34 (+5.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TNGX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TNGX Stock Price Chart Interactive Chart >

Price chart for TNGX

TNGX Price/Volume Stats

Current price $6.22 52-week high $18.84
Prev. close $5.88 52-week low $4.41
Day low $5.80 Volume 252,400
Day high $6.22 Avg. volume 224,134
50-day MA $6.80 Dividend yield N/A
200-day MA $10.13 Market Cap 546.72M

Tango Therapeutics, Inc. (TNGX) Company Bio


Tango Therapeutics, Inc., a biotechnology company, discovers and develops medicines for the treatment of cancer. Its lead program is TNG908, a protein arginine methyl transferase 5 inhibitor that is being developed as a treatment for cancers with MTAP deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor that treats cancers with BRCA1 mutations. Tango Therapeutics, Inc. has strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.


TNGX Latest News Stream


Event/Time News Detail
Loading, please wait...

TNGX Latest Social Stream


Loading social stream, please wait...

View Full TNGX Social Stream

Latest TNGX News From Around the Web

Below are the latest news stories about Tango Therapeutics Inc that investors may wish to consider to help them evaluate TNGX as an investment opportunity.

Tango Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in the following upcoming virtual investor conferences in February: Guggenheim 2022 Oncology Conference Date: Wednesday, February 9, 2022Time: 9:00 AM ET 11th Annual SVB Leerink Global Healthcare ConferenceDate:

Yahoo | February 2, 2022

Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates

- TNG908 IND cleared by FDA, Phase 1/2 trial expected to start in 1H 2022 - Additional pipeline programs progressing throughout 2022 CAMBRIDGE, Mass., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced progress updates across its pipeline and recent corporate highlights. “Last year we achieved a critical milestone, becoming a publicly-traded c

Yahoo | January 24, 2022

We're Interested To See How Tango Therapeutics (NASDAQ:TNGX) Uses Its Cash Hoard To Grow

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | January 11, 2022

Boxer Capital, Llc Buys Tyra Biosciences Inc, Tango Therapeutics Inc, Blueprint Medicines Corp, ...

Investment company Boxer Capital, Llc (Current Portfolio) buys Tyra Biosciences Inc, Tango Therapeutics Inc, Blueprint Medicines Corp, Fulcrum Therapeutics Inc, Turning Point Therapeutics Inc, sells Seagen Inc, Amarin Corp PLC, Therapeutics Acquisition Corp, , Agenus Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Boxer Capital, Llc.

Yahoo | December 21, 2021

Tango Therapeutics to Participate in the Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in the the Jefferies London Healthcare Conference. The presentation will be available on-demand starting at 8 AM GMT on Thursday, November 18, 2021. A webcast of the event will be available under the "Events & P

Yahoo | November 11, 2021

Read More 'TNGX' Stories Here

TNGX Price Returns

1-mo -15.83%
3-mo -30.73%
6-mo -37.74%
1-year -44.46%
3-year N/A
5-year N/A
YTD -43.14%
2021 -4.37%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5635 seconds.